The challenges we face
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help me?
Speak directly to a GM AHSN advisor with NHS expertise
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations
Connect you with relevant organisations
SBRI Healthcare announces details of next competition focused on cancer diagnosis, treatment and care
SBRI Healthcare is an NHS England funded initiative led by the Academic Health Science Networks to develop technology solutions for known healthcare challenges. The next funding round focuses on finding innovative solutions with the ability to transform screening, accelerated diagnosis and management of cancer.
Cancer remains one of the public’s most feared illnesses, affecting more than one in three of us in our lifetimes. This reality means that most of us will face the anxiety of ourselves or a loved one receiving this diagnosis at some point.
We know that improving the ability to diagnose cancer – to facilitate tests that are accessible and palatable will enhance our already record high survival rates. More than half of people receiving a cancer diagnosis will now live ten years or more. But we know there is much we could do to improve patient experience and long-term quality of life, and to make our care more patient-centred.
SBRI Healthcare welcome applications from companies with solutions that can enhance the screening, diagnosis or management of cancer. Successful applicants can receive up to £100,000 of funding for phase one (feasibility) and up to £1 million for phase two (development) for solutions that match the needs of the NHS.
Sign-up at www.sbrihealthcare.com to receive the full briefing document, which be available when the application process opens at the end of July. Briefing events are planned in London and Manchester in July. Details will be available shortly.